[China Cord Blood Corporation Receives Notice of Entry Into Conditional Sale Agreement HONG KONG, China, January 4 , 2017 - China Cord Blood Corporation In connection with the Share Purchase Agreement, other pending share sale arrangements entered into by Golden Meditech and Nanjing Xinjiekou Departm]
[China Cord Blood Corporation Receives Notice of Entry Into Conditional Sale Agreement HONG KONG, China, January 4 , 2017 - China Cord Blood Corporation In connection with the Share Purchase Agreement, other pending share sale arrangements entered into by Golden Meditech and Nanjing Xinjiekou Departm]
[Confidential Agreement to Terminate the Agreement to Purchase Assets by Share Issuance and Cash Payment By and among Nanjing Xinjiekou Department Store Co., Ltd. Golden Meditech Stem Cells (BVI) Company Limited and Golden Meditech Holdings Limited December 2016 Table of Contents Article 1 Definition]
[Confidential Agreement to Terminate the Agreement to Purchase Assets by Share Issuance and Cash Payment By and among Nanjing Xinjiekou Department Store Co., Ltd. Golden Meditech Stem Cells (BVI) Company Limited and Golden Meditech Holdings Limited December 2016 Table of Contents Article 1 Definition]
[China Cord Blood Corporation Announces Results of 201 Annual General Meeting HONG KONG, China, December 9 , 201 - China Cord Blood Corporation At the Annual General Meeting, shareholders · · About China Cord Blood Corporation China Cord Blood Corporation is the first and largest umbilical cord blood]
[China Cord Blood Corporation Announces Results of 201 Annual General Meeting HONG KONG, China, December 9 , 201 - China Cord Blood Corporation At the Annual General Meeting, shareholders · · About China Cord Blood Corporation China Cord Blood Corporation is the first and largest umbilical cord blood]
[FORM 6-K/A (Amendment No. 1) For the month December 2016 CHINA CORD BLOOD CORPORATION 48 th Floor, Bank of China Tower Hong Kong S.A.R. Form 20-F x o ¨ ¨ Yes ¨ x EXPLANATORY NOTE 2 Results of Operations and Financial Condition Following this cover page are the unaudited condensed consolidated financ]
[FORM 6-K/A (Amendment No. 1) For the month December 2016 CHINA CORD BLOOD CORPORATION 48 th Floor, Bank of China Tower Hong Kong S.A.R. Form 20-F x o ¨ ¨ Yes ¨ x EXPLANATORY NOTE 2 Results of Operations and Financial Condition Following this cover page are the unaudited condensed consolidated financ]
[China Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2017 2Q17 Added 18,037 New Subscribers 2Q17 Revenue Up 7.4% YOY to RMB184.1 Million ($27.6 Million) 2Q17 Operating Income Up 4.3% YOY to RMB54.7 Million ($8.2 Million) Conference Call to be Held on]
[China Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2017 2Q17 Added 18,037 New Subscribers 2Q17 Revenue Up 7.4% YOY to RMB184.1 Million ($27.6 Million) 2Q17 Operating Income Up 4.3% YOY to RMB54.7 Million ($8.2 Million) Conference Call to be Held on]
